Last update :
18/03/2025
References   References 4887  
Type : Manufacturer

Research teams :
Authors :
Title : IMJUDO (tremelimumab) 20 mg/mL concentrate for solution for infusion. Summary of Product Characteristics.
Reference : Astra Zenaca AB 2023

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionTremelimumab Anticancer drug
Stability in solutions Not specified NaCl 0,9% or Glucose 5% 0,1 >> 10 mg/ml 2-8°C Not specified
28 Day
Stability in solutions Not specified NaCl 0,9% or Glucose 5% 0,1 >> 10 mg/ml 25°C Not specified
48 Hour

  Mentions Légales